Food and Agricultural Immunology (Jan 2020)

Soya-cerebroside reduces interleukin production in human rheumatoid arthritis synovial fibroblasts by inhibiting the ERK, NF-κB and AP-1 signalling pathways

  • Hsiang-Ping Lee,
  • Yang-Chang Wu,
  • Bo-Cheng Chen,
  • Shan-Chi Liu,
  • Te-Mao Li,
  • Wei-Chien Huang,
  • Chin-Jung Hsu,
  • Chih-Hsin Tang

DOI
https://doi.org/10.1080/09540105.2020.1766426
Journal volume & issue
Vol. 31, no. 1
pp. 740 – 750

Abstract

Read online

Rheumatoid arthritis (RA) is characterised by the infiltration of a number of proinflammatory cytokines into synovial fluid. Soya-cerebroside, an extract from Cordyceps militaris, inhibits synovial inflammation and reduces cartilage damage in an osteoarthritis model, although the role of soya-cerebroside in inflammatory cytokine expression in RA is uncertain. In this study, Gene Expression Omnibus (GEO) database records revealed higher levels of interleukin (IL)-1β, IL-6 and IL-8 in RA tissue compared with normal tissue. Elevated levels of these inflammatory cytokines were also higher in mice with collagen-induced arthritis (CIA) than in control mice. Soya-cerebroside effectively inhibited IL-1β, IL-6 and IL-8 expression in RA synovial fibroblasts, apparently by inhibiting the ERK, NF-κB and AP-1 signalling pathways. This anti-inflammatory agent shows promise for the treatment of RA.

Keywords